LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.0016667
 53.04 27.76 4383 5365 0.8169 0.9474
MN20160318_Q01
N08
MCF 10A-H2B-mCherry Trametinib
0.0016667
 53.04 27.76 4405 5365 0.8210 0.9487
MN20160318_Q01
N08
MCF 10A-H2B-mCherry Trametinib
0.0016667
 54.74 27.76 3177 5606 0.5667 0.8570
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 54.74 27.76 3198 5606 0.5704 0.8586
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 54.74 27.76 4539 5606 0.8096 0.9456
MN20160318_Q01
N08
MCF 10A-H2B-mCherry Trametinib
0.0016667
 54.74 27.76 4560 5606 0.8133 0.9468
MN20160318_Q01
N08
MCF 10A-H2B-mCherry Trametinib
0.0016667
 56.45 27.76 3327 5745 0.5791 0.8629
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 56.45 27.76 3346 5745 0.5824 0.8643
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 56.45 27.76 4732 5745 0.8236 0.9502
MN20160318_Q01
N08
MCF 10A-H2B-mCherry Trametinib
0.0016667
 56.45 27.76 4758 5745 0.8281 0.9516
MN20160318_Q01
N08
MCF 10A-H2B-mCherry Trametinib
0.0016667
 58.15 27.76 3452 5906 0.5844 0.8658
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 58.15 27.76 3469 5906 0.5873 0.8670
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 58.15 27.76 4924 5906 0.8336 0.9535
MN20160318_Q01
N08
MCF 10A-H2B-mCherry Trametinib
0.0016667
 58.15 27.76 4952 5906 0.8384 0.9549
MN20160318_Q01
N08
MCF 10A-H2B-mCherry Trametinib
0.0016667
 59.85 27.76 3603 6062 0.5943 0.8705
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 59.85 27.76 3628 6062 0.5984 0.8721
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 59.85 27.76 5073 6062 0.8368 0.9547
MN20160318_Q01
N08
MCF 10A-H2B-mCherry Trametinib
0.0016667
 59.85 27.76 5095 6062 0.8404 0.9557
MN20160318_Q01
N08
MCF 10A-H2B-mCherry Trametinib
0.0016667
 61.56 27.76 3728 6217 0.5996 0.8732
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 61.56 27.76 3750 6217 0.6032 0.8746
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 61.56 27.76 5264 6217 0.8467 0.9578
MN20160318_Q01
N08
MCF 10A-H2B-mCherry Trametinib
0.0016667
 61.56 27.76 5290 6217 0.8509 0.9591
MN20160318_Q01
N08
MCF 10A-H2B-mCherry Trametinib
0.0016667
 63.26 27.76 3837 6465 0.5934 0.8716
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 63.26 27.76 3858 6465 0.5967 0.8729
MN20160318_Q01
C03
MCF 10A-H2B-mCherry Trametinib
0.0016667
 63.26 27.76 5403 6465 0.8357 0.9549
MN20160318_Q01
N08